News and Breakthroughs

When Candace Henley was diagnosed with colorectal cancer in 2003, she was a 35-year-old single mother raising five daughters. As a Black woman, she found herself feeling as though she was falling through the cracks in the healthcare system.

Award recipients are nominated by their colleagues and teammates for their skill, medical knowledge, and for going above and beyond expectations to provide exceptional and compassionate cancer care.

Blocking the arginine methylation pathway, which helps brain tumor cells proliferate by promoting cell division, could improve cancer therapies, according to a recent study.

Northwestern Medicine investigators have identified a protein kinase called DYRK1A and its downstream substrates as potential therapeutic targets for treating pediatric patients with B-cell acute lymphoblastic leukemia.

A new antibody drug demonstrated similar efficacy to currently available therapies to treat advanced ERBB2-positive breast cancer, according to a recent clinical trial.

Northwestern Medicine scientists have detailed the diverse function of CDK9-containing complexes and their impact on gene expression in a recent study published in the journal Genes and Development.

Northwestern Medicine investigators have identified a potential combined targeted therapy approach for treating glioblastoma, according to a recent study published in the journal Scientific Reports.

Lurie Cancer Center is teaming up with the National Comprehensive Cancer Network® (NCCN®), the American Cancer Society (ACS) and other leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.

Physician-scientist Melissa Simon wants to make health care work for everyone.

Seth Pollack, MD, a leading expert on immunotherapy strategies for treating sarcomas, has joined the Robert H. Lurie Comprehensive Cancer Center of Northwestern University as Medical Director of the Sarcoma Program. He is also the Steven T. Rosen, MD, Professor of Cancer Biology and associate professor of Medicine in the Division of Hematology and Oncology at the Feinberg School of Medicine.